At a glance
ClinicalIndex Comparison RecordN/AActive· 14,966 enrolled
Drug / intervention
As the LEAD study is an observational cohort study, there is no intervention to report.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Austrian LEAD (Lung hEart sociAl boDy) Study
In Brief
An observational study evaluating As the LEAD study is an observational cohort study, there is no intervention to report. for Respiration Disorders and 2 related conditions. Active but no longer recruiting, targeting 14,966 participants across 1 site.
Detailed Summary
The LEAD study is the first longitudinal cohort investigating respiratory, cardiac, and metabolic health in a reference population of Austria.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria
Collaborators--
Timeline
N/AActive
201220132014201520162017201820192020202120222023202420252026202720282029
Enrollment StartOct 2011
First PostedNov 2012
Primary CompletionOct 2016
TodayJul 2026
Study CompletionOct 2028
First PostedNov 16, 2012
Enrollment StartOct 1, 2011
Primary CompletionOct 1, 2016
Study CompletionOct 1, 2028
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 13.6 years ago
Interventions
As the LEAD study is an observational cohort study, there is no intervention to report.other
As the LEAD study is an observational cohort study, there is no intervention to report.